To compare the clinical efficacy of Jianpi Shengxue Tablet and iron dextran tablet in treating gestational iron deficiencyanemia and to provide a basis in treatment.Methods:A total of 180 patients with gestational iron deficiencyanemia treated in Qinghai Provincial People's Hospital from January 2015 to January 2017 were selected and randomly divided into the control group and the observation group,with 90 patients in each group.The control group was given iron dextran tablet,and the observation group was given Jianpi Shengxue Tablet.After 3 months continuous treatment,the clinical efficacy,levels of RBC,Hb and SF in both groups were observed,and their adverse reactions were recorded.Results:The clinical effect rate of the control group and the observation group were 74.16% and 92.05%,and the rate of observation group was higher (P<0.05).Compared with before the treatment,the RBC,Hb,SF levels of both groups were increased (P<0.05),and every index of observation group was increased more than the control group (P<0.05).The adverse reactions of the observation group was better than the control group,but there was no statistical difference (P>0.05).Conclusion:There was a significant curative effect of Jianpi Shengxue Tablet in treatment of gestational iron deficiencyanemia.Jianpi Shengxue Tablet is more effective than dextran iron tablets,which is worthy of clinical application.